Clinical and virological effects of long-term (over 5 years) lamivudine therapy-Reference-Cited by-同舟云学术

Clinical and virological effects of long-term (over 5 years) lamivudine therapy

Published:2010-02-17 Issue:4 Volume:82 Page:684-691
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Hashimoto Yoshimasa,Suzuki Fumitaka,Hirakawa Miharu,Kawamura Yusuke,Yatsuji Hiromi,Sezaki Hitomi,Hosaka Tetuya,Akuta Norio,Kobayashi Masahiro,Saito Satoshi,Suzuki Yoshiyuki,Kobayashi Mariko,Arase Yasuji,Ikeda Kenji,Kumada Hiromitsu

Funder

Ministry of Health, Labor and Welfare, Japan (partial support)

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.21681/fullpdf

Reference31 articles.

1. Virological and biochemical relapse according to YMDD motif mutant type during long-term lamivudine monotherapy;Akuta;J Med Virol,2003

2. Virological and biochemical relapse after discontinuation of lamivudine monotherapy for chronic hepatitis B in Japan: Comparison with breakthrough hepatitis during long-term treatment;Akuta;Intervirology,2005

3. Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance;Baldick;Hepatology,2008

4. Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B;Chang;J Hepatol,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution and diversity of the hepatitis B virus genome: Clinical implications;Virology;2024-10

2. The impact of early hepatitis B virus viral suppression on treatment response in entecavir‐treated hepatitis B e antigen‐positive chronic hepatitis B;Advances in Digestive Medicine;2023-04-12

3. Inflammation Pharmacological Reaction and YMDD Mutational Patterns in Lamivudine Therapeutics Hepatitis B Virus;Frontiers in Pharmacology;2021-04-15

4. Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B;PLOS ONE;2019-08-30

5. A case of liver cirrhosis with multidrug-resistant hepatitis B virus that responded to interferon therapy;Kanzo;2019-02-20